Effect of sulphonylurea on insulin secretion and glucose control in insulin-treated diabetics.
作者信息
Ward E A, Ward G M, Turner R C
出版信息
Br Med J (Clin Res Ed). 1981 Jul 25;283(6286):278. doi: 10.1136/bmj.283.6286.278.
Abstract
摘要
相似文献
1
Effect of sulphonylurea on insulin secretion and glucose control in insulin-treated diabetics.
Br Med J (Clin Res Ed). 1981 Jul 25;283(6286):278. doi: 10.1136/bmj.283.6286.278.
2
Effect of the alpha-glucosidase-inhibitor BAY-g-5421 on blood glucose control of sulphonylurea-treated diabetics and insulin-treated diabetics.
Diabetologia. 1979 Nov;17(5):287-90. doi: 10.1007/BF01235884.
3
Clinical comparison between glipentide (Staticum) and glibenclamide in diabetics.格列戊脲（司达立）与格列本脲治疗糖尿病的临床比较
Curr Ther Res Clin Exp. 1977 Jan;21(1):50-7.
4
Mild familial diabetes with dominant inheritance.轻度显性遗传家族性糖尿病。
Q J Med. 1974 Apr;43(170):339-57.
5
Glibenclamide, a new sulphonylurea: whither oral hypoglycaemic agents?格列本脲，一种新型磺酰脲类药物：口服降糖药何去何从？
Drugs. 1971;1(2):109-15. doi: 10.2165/00003495-197101020-00001.
6
[Longtime effect of blood sugar decreasing sulfonamides on glucose tolerance and insulin secretion in adult diabetic patients].
Verh Dtsch Ges Inn Med. 1973;79:1216-20.
7
[Glibenclamide in type II diabetes as compared with placebo].
Wien Klin Wochenschr. 1983 Mar 18;95(6):200-3.
8
9
Sulphonylurea and insulin: combined treatment in type 1 (insulin-dependent) diabetes.磺酰脲类药物与胰岛素：1型（胰岛素依赖型）糖尿病的联合治疗
Diabetologia. 1985 Mar;28(3):182. doi: 10.1007/BF00273870.
10
Progress in oral therapy of diabetes mellitus with sulphonylureas of the second generation.
Acta Diabetol Lat. 1972 Nov-Dec;9(6):865-99. doi: 10.1007/BF01564590.
引用本文的文献
1
Tolbutamide does not alter insulin requirement in Type 1 (insulin-dependent) diabetes.甲苯磺丁脲不会改变1型（胰岛素依赖型）糖尿病患者的胰岛素需求量。
Diabetologia. 1984 Jul;27(1):8-12. doi: 10.1007/BF00253493.
2
Sulphonylurea and insulin: combined treatment in type 1 (insulin-dependent) diabetes.磺酰脲类药物与胰岛素：1型（胰岛素依赖型）糖尿病的联合治疗
Diabetologia. 1985 Mar;28(3):182. doi: 10.1007/BF00273870.
3
The insulin receptor concept and its relation to the treatment of diabetes.胰岛素受体概念及其与糖尿病治疗的关系。
Drugs. 1987 Feb;33(2):156-70. doi: 10.2165/00003495-198733020-00004.
本文引用的文献
1
Direct in vitro effect of a sulfonylurea to increase human fibroblast insulin receptors.一种磺脲类药物增加人成纤维细胞胰岛素受体的直接体外效应。
J Clin Invest. 1980 Sep;66(3):608-11. doi: 10.1172/JCI109894.
2
Determination of free and total insulin and C-peptide in insulin-treated diabetics.胰岛素治疗糖尿病患者中游离及总胰岛素和C肽的测定
Diabetes. 1977 Jan;26(1):22-9. doi: 10.2337/diab.26.1.22.
3
C-peptide secretion and insulin antibodies as determinants of stability in diabetes mellitus.
Metabolism. 1978 Jan;27(1):35-44. doi: 10.1016/0026-0495(78)90121-x.
4
C-peptide in juvenile diabetics beyond the postinitial remission period. Relation to clinical manifestations at onset of diabetes, remission and diabetic control.
Acta Paediatr Scand. 1977 Mar;66(2):177-84. doi: 10.1111/j.1651-2227.1977.tb07830.x.
5
A simple and rational twice daily insulin regime. Distinction between basal and meal insulin requirements.
Q J Med. 1979 Jul;48(191):493-506.
Zotero 插件